彩民宝典

Angela Bryan had been studying cancer prevention for years and had just started studying cannabis use among cancer patients when, in 2017, her personal and professional lives collided in a way she鈥檇 never imagined: She was diagnosed with breast cancer.

Hesitant to take opioids for post-surgical pain, she asked her doctors what they thought about her using the herb medicinally.

鈥淭hey were so supportive of what I wanted to do, but they had no idea what to tell me,鈥� said Bryan, a professor of psychology and neuroscience at 彩民宝典. 鈥淭here was just no data.鈥�

Fast forward six years, and a small but groundbreaking study helps to fill that gap, showing that cancer patients who use cannabis to address their symptoms have less pain, sleep better and experience another, unexpected, benefit:

After a few weeks of sustained use, they seem to think more clearly.

鈥淲hen you鈥檙e in a lot of pain, it鈥檚 hard to think,鈥� said Bryan, the study鈥檚 senior author. 鈥淲e found that when patients鈥� pain levels came down after using cannabis for a while, their cognition got better.鈥�

The study, published April 26听 is among the first to assess how cannabis bought over the counter at dispensaries鈥攔ather than government-supplied or synthetic varieties鈥攊mpacts cancer symptoms or chemotherapy side effects.

It also sheds light on the wide variety of products cancer patients use now that marijuana is legal in most states.

Bringing the lab to the patients

Surveys suggest that as many as 40% of U.S. cancer patients use cannabis, yet only a third of doctors feel comfortable advising them about it.

Studying it is complicated, because federal law prohibits university researchers from possessing or distributing cannabis for research unless it鈥檚 government-issued or of pharmaceutical grade. As a result, most studies have looked only at prescription products like nabilone or dronabinol (typically prescribed for nausea) or government cannabis strains that tend to be less potent and lack the variety of over-the-counter offerings.

For the study, Bryan collaborated with oncologists Dr. Ross Camidge and Dr. Daniel Bowles at the CU Anschutz Medical Campus to observe 25 cancer patients who used cannabis over two weeks.

After a baseline appointment in which their pain levels, sleep patterns and cognition were assessed, they were asked to purchase the edible product of their choosing from a dispensary. Choices were surprisingly varied, spanning 18 brands, including chocolates, gummies, tinctures, pills, and baked goods, and contained varying ratios of THC and CBD at a wide range of potencies.

鈥淭his tells us that people are open to trying whatever they think might be useful, but there鈥檚 just not much data out there to guide them on what works best for what,鈥� said Bryan.

To study acute impacts, researchers drove a 鈥�mobile laboratory鈥� (a Dodge Sprinter van sometimes referred to as the 鈥渃annavan鈥�) to each patient鈥檚 home one day. Participants underwent physical and cognitive assessments in the van, then re-tested in the van after using cannabis in their homes.

After two weeks of sustained use at the frequency of their choice, they also had a follow-up exam.

Within an hour, the study found, cannabis eased patient鈥檚 pain significantly while also impairing their cognition and making them feel 鈥渉igh鈥� (the higher the THC content, the higher they felt).

But longer term, a different pattern emerged: After two weeks of sustained use, patients reported improvements in pain, sleep quality and cognitive function. Some objective measures of cognitive function, including reaction times, also improved.

鈥淲e thought we might see some problems with cognitive function,鈥� said Bryan, noting that both cannabis and chemotherapy have been previously associated with impaired thinking. 鈥淏ut people actually felt like they were thinking more clearly. It was a surprise.鈥�

The more people鈥檚 pain subsided, the more their cognition seemed to improve.

Notably, those who ingested more CBD, a known anti-inflammatory, reported bigger improvements in both pain intensity and sleep quality.

While larger, controlled studies are needed before drawing conclusions, the authors say the findings raise an intriguing possibility: While some forms and dosages of cannabis for pain relief may impair thinking short-term, some might improve cognition in the long run by reducing pain.

鈥淲e know oncologists and patients are concerned about the possible negative impact of cancer treatment on cognitive function, so the potential, indirect role of cannabis use on improving subjective cognitive function should be studied further,鈥� said first author Gregory Giordano, a professional research assistant in the Department of Psychology and Neuroscience.

Personal experience

After surgery and chemotherapy, Bryan did turn to cannabis-infused edibles, creating her own custom regimen of more potent THC-heavy products when pain was intense and she could sacrifice some mental sharpness, and milder, CBD-heavy products to keep the pain manageable.

She was not pain-free, but she didn鈥檛 take a single opiate during her treatment.

鈥淚 was extremely lucky because I had some knowledge about this. Most patients don鈥檛,鈥� she said. 鈥淓ither they don鈥檛 know it鈥檚 an option or they鈥檝e got well-meaning but potentially under-informed budtenders advising them.鈥�

She hopes her team鈥檚 research, and more studies to come, will enable doctors and patients to make better-informed decisions.